scout.yahoo.com
Yahoo Scout
Yahoo Scout
淮安一化工厂爆炸
Searching…
Web results
crohnsandcolitis.org.uk
Ustekinumab biosimilars: what you need to know
Ustekinumab biosimilars: what you need to know From September 2024, biosimilar versions of ustekinumab will become available in the UK. This is happening because the patent for Stelara, the brandname for the original ...
www.healthline.com
Stelara vs. Humira: Is One of Them Right for You? - Healthline
Apr 12, 2024 · Stelara (ustekinumab) and Humira (adalimumab) are prescription drugs used to treat certain autoimmune or inflammatory conditions. Both are injectable biologic medications.
www.psoriasis-association.org.uk
Ustekinumab for psoriasis
UstekinumabUstekinumab is a biologic medication that is used to treat severe psoriasis and/or psoriatic arthritis. It is known by the brandnames Stelara, Steqeyma, Pyzchiva, Uzpruvo and Wezenla. Please note: Previousl...
www.drugs.com
Imuldosa: Uses, Dosage, Side Effects, Warnings - Drugs.com
Oct 30, 2024 · Imuldosa (ustekinumab-srlf) is a biosimilar to Stelara that may be used to treat Crohn's disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic arthritis.
pubmed.ncbi.nlm.nih.gov
Off-label uses of ustekinumab - PubMed
Abstract Ustekinumab (brandname Stelara®) is a human interleukin-12 and -23 antagonist and has been indicated for the treatments of moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerat...
www.wmic.wales.nhs.uk
Ustekinumab – switching to biosimila
Why you have received this leaflet You are currently being treated with a medicine called ustekinumab (brandname Stelara®). Until recently ustekinumab was produced by only one manufacturer.
pharmac.govt.nz
Decision to fund ustekinumab for inflammatory bowel disease ...
Dec 20, 2022 · In summary: ustekinumab (brandname Stelara) will be funded for the treatment of people with inflammatory bowel disease (ulcerative colitis or Crohn’s disease) that has not responded to prior biologic th...